Tariffs and Pharmaceutical Technology Transfer: What Sponsors Need to Anticipate When a late-stage biologic transitions from a U.S. development site to an EU commercial manufacturing
Life sciences organizations today face sustained pressure to initiate new programs, expand into global markets, and comply with increasingly rigorous regulatory requirements. As programs grow
Life sciences organizations today face growing pressure to launch new programs, expand into global markets, and comply with increasingly stringent regulatory requirements. We often see
Life sciences organizations today operate under sustained pressure to launch new programs, expand into global markets, and comply with increasingly rigorous regulatory requirements. Expectations continue
Life sciences organizations are under mounting pressure to advance new programs, enter global markets, and comply with increasingly stringent regulatory expectations. In many cases, the
Life sciences organizations face increasing pressure to initiate new programs, expand into global markets, and meet evolving regulatory expectations. In our experience, many teams are